With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006
Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety
Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved
Newest MDR-TB drug prices could fall by up to 95% through generic production
TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis
Three-month isoniazid/pyrazinamide regimen prevents TB as well as 6-month isoniazid in people living with HIV
Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis
